GB0223272D0 - A protein involved in therapy - Google Patents

A protein involved in therapy

Info

Publication number: GB0223272D0
Authority: GB; United Kingdom
Prior art keywords: therapy; protein involved; protein; involved
Prior art date: 2002-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0223272A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Oxford Glycosciences UK Ltd

Original Assignee

Bayer AG

Oxford Glycosciences UK Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-08

Filing date

2002-10-08

Publication date

2002-11-13

2002-10-08 Application filed by Bayer AG, Oxford Glycosciences UK Ltd filed Critical Bayer AG

2002-10-08 Priority to GB0223272A priority Critical patent/GB0223272D0/en

2002-11-13 Publication of GB0223272D0 publication Critical patent/GB0223272D0/en

2003-10-08 Priority to AU2003269257A priority patent/AU2003269257A1/en

2003-10-08 Priority to PCT/GB2003/004341 priority patent/WO2004034062A2/en

Status Ceased legal-status Critical Current

Links

GB0223272A 2002-10-08 2002-10-08 A protein involved in therapy Ceased GB0223272D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GB0223272A GB0223272D0 (en)	2002-10-08	2002-10-08	A protein involved in therapy
AU2003269257A AU2003269257A1 (en)	2002-10-08	2003-10-08	Use of cap-1 for the therapy of asthma
PCT/GB2003/004341 WO2004034062A2 (en)	2002-10-08	2003-10-08	Use of cap-1 for the therapy of asthma

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0223272A GB0223272D0 (en)	2002-10-08	2002-10-08	A protein involved in therapy

Publications (1)

Publication Number	Publication Date
GB0223272D0 true GB0223272D0 (en)	2002-11-13

Family

ID=9945455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0223272A Ceased GB0223272D0 (en)	2002-10-08	2002-10-08	A protein involved in therapy

Country Status (3)

Country	Link
AU (1)	AU2003269257A1 (en)
GB (1)	GB0223272D0 (en)
WO (1)	WO2004034062A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2756762A1 (en) *	2009-03-30	2010-10-07	Protab Ltd.	Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
WO2013022262A2 (en) *	2011-08-08	2013-02-14	서울대학교병원	Human resistin receptor, and use thereof
KR101473526B1 (en) *	2011-08-08	2014-12-22	서울대학교병원	Human resistin receptor and use thereof
KR102040974B1 (en)	2017-01-31	2019-11-06	서울대학교병원	Polypeptides that were derived from adenylyl cyclase-associated protein 1(CAP1) and pharmaceutical composition comprising the same
AU2020433744A1 (en) *	2020-03-02	2022-09-22	Seoul National University Hospital	Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001271536A1 (en) *	2000-06-29	2002-01-14	Incyte Genomics, Inc.	Adenylyl and guanylyl cyclases
AU2002237228A1 (en) *	2000-12-11	2002-06-24	Bayer Aktiengesellschaft	Regulation of human adenylate cyclase, type vii
US6706688B2 (en) *	2001-03-09	2004-03-16	Paula Sundstrom	Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1
GB0213964D0 (en) *	2002-06-18	2002-07-31	Oxford Glycosciences Uk Ltd	Protein

2002
- 2002-10-08 GB GB0223272A patent/GB0223272D0/en not_active Ceased
2003
- 2003-10-08 AU AU2003269257A patent/AU2003269257A1/en not_active Abandoned
- 2003-10-08 WO PCT/GB2003/004341 patent/WO2004034062A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004034062A2 (en)	2004-04-22
AU2003269257A8 (en)	2004-05-04
WO2004034062A3 (en)	2004-06-03
AU2003269257A1 (en)	2004-05-04

Similar Documents

Publication	Publication Date	Title
GB0206033D0 (en)	2002-04-24	Compounds useful in therapy
GB0219776D0 (en)	2002-10-02	A protein involved in carcinoma
AU2003227861A8 (en)	2003-10-27	Protein involved in cancer
GB0223272D0 (en)	2002-11-13	A protein involved in therapy
GB0224014D0 (en)	2002-11-27	A protein involved in therapy
GB0224013D0 (en)	2002-11-27	A protein involved in therapy
GB0201808D0 (en)	2002-03-13	Protein
GB0229902D0 (en)	2003-01-29	A protein involved in therapy
GB0223292D0 (en)	2002-11-13	A protein involved in therapy
GB0223958D0 (en)	2002-11-20	A protein involved in therapy
AU2003278718A8 (en)	2004-03-11	Stars-a muscle-specification-binding protein
GB0202748D0 (en)	2002-03-27	Protein
GB0213964D0 (en)	2002-07-31	Protein
GB0204735D0 (en)	2002-04-17	Protein
GB0221538D0 (en)	2002-10-23	A protein involved in carcinoma
GB0222483D0 (en)	2002-11-06	A protein involved in carcinoma
GB0221488D0 (en)	2002-10-23	A protein involved in carcinoma
GB0308327D0 (en)	2003-05-14	A protein involved in cancer
GB0221487D0 (en)	2002-10-23	A protein involved in pancreatic cancer
GB0229875D0 (en)	2003-01-29	Protein involved in cancer
GB0230023D0 (en)	2003-01-29	A new protein
GB0228311D0 (en)	2003-01-08	A new protein
GB0202669D0 (en)	2002-03-20	Protein
GB0203165D0 (en)	2002-03-27	Protein
GB0202666D0 (en)	2002-03-20	Protein

Legal Events

Date	Code	Title	Description
2004-01-07	AT	Applications terminated before publication under section 16(1)